We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,203 results
  1. Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

    Background

    Compelling evidence exists for the iso-effectiveness and safety of moderate hypofractionated radiotherapy (Hypo-RT) schedules [1, 2]....

    Wolfgang Lilleby, Amar Kishan, Hans Geinitz in World Journal of Urology
    Article Open access 20 January 2024
  2. Moderate hypofractionated radiation therapy and pathologic response for soft tissue sarcomas (STS) of limbs and trunk: experience from a tertiary cancer center

    Background

    Preoperative radiation therapy following by limb-sparing or conservative surgery is a standard approach for limb and trunk STS. Data...

    Angel Montero, **n Chen-Zhao, ... Carmen Rubio in Clinical and Translational Oncology
    Article 05 June 2023
  3. Moderately hypofractionated versus conventionally fractionated radiation therapy with temozolomide for young and fit patients with glioblastoma: an institutional experience and meta-analysis of literature

    Purpose

    Shorter hypofractionated radiation therapy (HF-RT) schedules may have radiobiological, patient convenience and healthcare resource advantages...

    Phoebe Chidley, Mihir Shanker, ... Joseph Sia in Journal of Neuro-Oncology
    Article Open access 10 November 2022
  4. Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis

    Background

    The boost to the tumor bed improves local control in breast cancer and it is an important part of the breast conserving therapy. However,...

    Gabriela Oses, Tanny Daniela Barreto, ... Meritxell Mollà in Clinical and Translational Oncology
    Article 22 March 2023
  5. Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer

    Background

    Prostate cancer is the second most common malignancy in men, and its incidence is increasing which is attributed to increased screening...

    Eileen Samuel, Saliha Zaman, ... Muhammad Mohsin Fareed in Discover Oncology
    Article Open access 02 February 2024
  6. Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer

    Purpose of Review

    The goal is to describe the evolution of radiation therapy (RT) utilization in the management of localized and metastatic prostate...

    Malcolm D. Mattes in Current Urology Reports
    Article 11 June 2024
  7. Changes in Radiation Therapy: New Ultrahypofractionated Radiation, Repeat Breast Conservation Therapy in the Management of Breast Recurrence with Re-irradiation, Proton Therapy

    Purpose of Review

    Management of breast cancer is multidisciplinary, balancing local and systemic control between treatment modalities. Surgical,...

    Kristin M. Lupinacci, Quratulain (Anna) Sabih, ... Emilia J. Diego in Current Breast Cancer Reports
    Article 21 March 2024
  8. Favorable outcome in advanced pheochromocytoma and paraganglioma after hypofractionated intensity modulated radiotherapy

    Purpose

    The purpose of this study was to review outcomes of patients with advanced/metastatic pheochromocytoma/paraganglioma (PPGL) treated at our...

    Z. Gu, K. Hu, ... X. Hou in Journal of Endocrinological Investigation
    Article 19 September 2022
  9. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

    Purpose

    We aimed to evaluate the prognostic factors and the role of stereotactic radiotherapy (SRT) as a re-irradiation technique in the management of...

    Melek Tugce Yilmaz, Alper Kahvecioglu, ... Faruk Zorlu in Journal of Neuro-Oncology
    Article Open access 22 February 2024
  10. Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trial

    Purpose

    Concurrent chemoradiation has been the mainstay of treatment for cervix cancer. We aimed to evaluate the non-inferiority of hypofractionated...

    Afsane Maddah Safaei, Ebrahim Esmati, ... Kasra Kolahdouzan in Journal of Cancer Research and Clinical Oncology
    Article Open access 20 January 2024
  11. Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)

    Background

    Moderate hypofractionated radiotherapy is a treatment option for the cure of localized prostate cancer (PCa) patients based on the results...

    Gianluca Ingrosso, Elisabetta Ponti, ... Beatrice Detti in La radiologia medica
    Article Open access 19 February 2024
  12. Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group

    Introduction

    Daily, moderate hypofractionation has become standard treatment for breast cancer following breast-conserving surgery, although...

    Arantxa Eraso, Javier Sanz, ... Manuel Algara in Clinical and Translational Oncology
    Article Open access 21 February 2022
  13. A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer

    Background

    The aim of this multi-institutional phase II study was to confirm the safety and the potential efficacy of moderately hypofractionated...

    Katsumasa Nakamura, Keiji Nihei, ... Yoshikazu Kagami in International Journal of Clinical Oncology
    Article 17 April 2024
  14. Immune Priming with Spatially Fractionated Radiation Therapy

    Purpose of Review

    This review aims to summarize the current preclinical and clinical evidence of nontargeted immune effects of spatially fractionated...

    Lauren Lukas, Hualin Zhang, ... Alan Epstein in Current Oncology Reports
    Article Open access 18 November 2023
  15. Single fraction and hypofractionated radiosurgery for perioptic meningiomas—tumor control and visual outcomes: a systematic review and meta-analysis

    Perioptic meningiomas, defined as those that are less than 3 mm from the optic apparatus, are challenging to treat with stereotactic radiosurgery...

    David R. Peters, Anthony Asher, ... Constantin Tuleasca in Neurosurgical Review
    Article 28 October 2023
  16. Let’s make size not matter: tumor control and toxicity outcomes of hypofractionated Gamma Knife radiosurgery for large brain metastases

    Purpose

    Management of patients with large brain metastases poses a clinical challenge, with poor local control and high risk of adverse radiation...

    Akash Mishra, Daniel Koffler, ... Anuj Goenka in Journal of Neuro-Oncology
    Article 06 July 2023
  17. Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study

    Purpose

    The purpose of this planning study was to develop an acceptable technique for highly hypofractionated intensity-modulated radiation therapy...

    Ryo Ashida, Kiyonao Nakamura, ... Takashi Mizowaki in Japanese Journal of Radiology
    Article 05 August 2021
  18. Nodal and osseous oligometastatic prostate cancer: a cohort including the introduction of PSMA-PET/CT-guided stereotactic and hypofractionated radiotherapy with elective nodal therapy

    Purpose

    Oligometastatic prostate cancer is heavily investigated, and conventionally fractionated elective nodal treatment appears to increase...

    Ahmed Gawish, Matthias Walke, ... Thomas B. Brunner in Journal of Cancer Research and Clinical Oncology
    Article Open access 27 August 2022
  19. Dosimetric impact of rectum and bladder anatomy and intrafractional prostate motion on hypofractionated prostate radiation therapy

    Objective

    The objective of this study was to evaluate the dosimetric impact on hypofractionated prostate radiation therapy of two geometric...

    M. Roch, A. Zapatero, ... F. García-Vicente in Clinical and Translational Oncology
    Article 28 April 2021
  20. Moderate hypofractionated post-prostatectomy radiation therapy is feasible and well tolerated: experience from a single tertiary cancer centre

    Purpose

    Conventional post-prostatectomy radiation therapy comprises 6.5–8 weeks of treatment, therefore, hypofractionated and shortened schemes arouse...

    J. Valero, A. Montero, ... C. Rubio in Clinical and Translational Oncology
    Article 12 January 2021
Did you find what you were looking for? Share feedback.